# Radioisotope Scintigraphy to Establish Incidence of Cardiac Amyloidosis Among Patients With Otherwise Unexplained Cardiac Disease

> **NCT03098901** · NA · UNKNOWN · sponsor: **Kaplan Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Cardiac TTR Amyloidosis

## Interventions

- **DIAGNOSTIC_TEST:** Tc99m-labeled pyrophosphate scan

## Key facts

- **NCT ID:** NCT03098901
- **Lead sponsor:** Kaplan Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-15
- **Primary completion:** 2018-04-15
- **Final completion:** 2018-04-15
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03098901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03098901, "Radioisotope Scintigraphy to Establish Incidence of Cardiac Amyloidosis Among Patients With Otherwise Unexplained Cardiac Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03098901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*